Patient Guide: Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008/KEYSTEP-008)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 109 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04895722
Status: ACTIVE_NOT_RECRUITING
Condition: Colorectal Cancer
Phase: PHASE2

Find a Study Location Near You

This study is available at 109 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Orange City, Florida
  • Athens, Georgia
  • Chicago, Illinois
  • • And 106 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily